We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current UTHR market cap is 12.35B. The company's latest EPS is USD 20.9271 and P/E is 12.54.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 516M | 491.5M | 506.9M | 596.5M | 609.4M |
| Operating Income | 314.3M | 175.6M | 284.4M | 313.4M | 327M |
| Net Income | 239.3M | 132.1M | 240.9M | 259.2M | 267.6M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.45B | 1.48B | 1.69B | 1.94B | 2.33B |
| Operating Income | -187.6M | 593.6M | 442.5M | 979.7M | 1.18B |
| Net Income | -104.5M | 514.8M | 362.4M | 727.3M | 984.8M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 5.78B | 6.04B | 6.35B | 6.68B | 7.02B |
| Total Liabilities | 1.22B | 1.25B | 1.22B | 1.27B | 1.31B |
| Total Equity | 4.56B | 4.8B | 5.12B | 5.41B | 5.71B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 3.91B | 4.62B | 5.17B | 6.04B | 7.17B |
| Total Liabilities | 1.13B | 1.22B | 1.21B | 1.25B | 1.18B |
| Total Equity | 2.78B | 3.4B | 3.96B | 4.8B | 5.98B |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 674.3M | 802.5M | 374.8M | 481.1M | 827.3M |
| Investing | -622.2M | -811.5M | -221.1M | -448.3M | -761.7M |
| Financing | 19.9M | 75.4M | 48.6M | 73.3M | 80.9M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -206.6M | 755.7M | 598.2M | 802.5M | 978M |
| Investing | -335.4M | -738.5M | -486.9M | -811.5M | -719.6M |
| Financing | 611.2M | -16.9M | 44.8M | 75.4M | -11.9M |
| Market Cap | 12.35B |
| Price to Earnings Ratio | 12.54 |
| Price to Sales Ratio | 5.31 |
| Price to Cash Ratio | 10.22 |
| Price to Book Ratio | 2.06 |
| Dividend Yield | - |
| Shares Outstanding | 47.06M |
| Average Volume (1 week) | 722.72k |
| Average Volume (1 Month) | 543.02k |
| 52 Week Change | 19.27% |
| 52 Week High | 262.51 |
| 52 Week Low | 204.44 |
| Spread (Intraday) | 64.3 (23.02%) |
| Company Name | United Therapeutics Corporation |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.unither.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
